EQS-News: q.beyond AG / Key word (s): Preliminary Results/Forecast q.beyond increases EBITDA by 84% to € 10.5 million and exceeds expectations 05.03.2025 / 07:30 CET/CEST The issuer is solely ...
Corbion successfully met its upgraded targets for sales and Adjusted EBITDA, while significantly surpassing our free cash flow target. We achieved organic sales growth and double-digit increases ...
Sales declined 0.9% organically, with volumes down 4% while prices rose 3.1%. For 2025, Bayer projects sales growth of 2% to ...
Adjusted EBITDA* of SEK -26.6 million (-27.7), representing a -111% margin, -13%p. y/y and -45%p. q/q. Free Cash Flow of SEK -15.1 million (-37.6), representing a -63% FCF margin, 22%p.